Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Douglas Weaver

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
JAMA|January 5, 2012
International variation in and factors associated with hospital readmission after myocardial infarctionRobb D Kociol, Renato D Lopes, Robert Clare, et al.
American Heart Journal|July 3, 2002
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteriesR David Anderson, Harvey D White, E Magnus Ohman, et al.
JAMA|June 19, 2002
Early statin initiation and outcomes in patients with acute coronary syndromesL Kristin Newby, Arni Kristinsson, Manjushri V Bhapkar, et al.
American Heart Journal|November 27, 2008
Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006C Michael Gibson, Yuri B Pride, Paul D Frederick, et al.
American Heart Journal|March 1, 2006
Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trialAdam B Greenbaum, Cindy L Grines, John A Bittl, et al.
European Heart Journal|April 14, 2006
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL studyAbhinav Goyal, Kenneth W Mahaffey, Jyotsna Garg, et al.
American Heart Journal|March 30, 2013
Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarctionAnjan K Chakrabarti, Kristin Feeney, Cassandra Abueg, et al.
Journal of the American College of Cardiology|July 4, 2006
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trialMichael P Hudson, Paul W Armstrong, Witold Ruzyllo, et al.
The American Journal of Cardiology|February 22, 2005
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)Manesh R Patel, Kenneth W Mahaffey, Paul W Armstrong, et al.
The American Journal of Cardiology|August 14, 2003
Transcutaneous ultrasound-facilitated coronary thrombolysis during acute myocardial infarctionMauricio G Cohen, Enrique Tuero, Jorge Bluguermann, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
JAMA|January 5, 2012
International variation in and factors associated with hospital readmission after myocardial infarctionRobb D Kociol, Renato D Lopes, Robert Clare, et al.
American Heart Journal|July 3, 2002
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteriesR David Anderson, Harvey D White, E Magnus Ohman, et al.
JAMA|June 19, 2002
Early statin initiation and outcomes in patients with acute coronary syndromesL Kristin Newby, Arni Kristinsson, Manjushri V Bhapkar, et al.
American Heart Journal|November 27, 2008
Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006C Michael Gibson, Yuri B Pride, Paul D Frederick, et al.
American Heart Journal|March 1, 2006
Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trialAdam B Greenbaum, Cindy L Grines, John A Bittl, et al.
European Heart Journal|April 14, 2006
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL studyAbhinav Goyal, Kenneth W Mahaffey, Jyotsna Garg, et al.
American Heart Journal|March 30, 2013
Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarctionAnjan K Chakrabarti, Kristin Feeney, Cassandra Abueg, et al.
Journal of the American College of Cardiology|July 4, 2006
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trialMichael P Hudson, Paul W Armstrong, Witold Ruzyllo, et al.
The American Journal of Cardiology|February 22, 2005
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)Manesh R Patel, Kenneth W Mahaffey, Paul W Armstrong, et al.
The American Journal of Cardiology|August 14, 2003
Transcutaneous ultrasound-facilitated coronary thrombolysis during acute myocardial infarctionMauricio G Cohen, Enrique Tuero, Jorge Bluguermann, et al.
Pageof 9